AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
National Cancer Institute (U.S.)National Institutes of Health (U.S.)United StatesNeoplasmsEarly Detection of CancerBreast NeoplasmsRegistriesSEER ProgramProstatic NeoplasmsLung NeoplasmsAntineoplastic AgentsNational Health ProgramsOvarian NeoplasmsCancer Care FacilitiesIncidenceSurvival RateMedical OncologySurvival AnalysisStomach NeoplasmsRetrospective StudiesColonic NeoplasmsClinical Trials as TopicAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesAge FactorsDrug Screening Assays, AntitumorPrognosisRisk FactorsNeoplasm StagingNeoplasm MetastasisTreatment OutcomeColorectal NeoplasmsNeoplasm InvasivenessPancreatic NeoplasmsRisk AssessmentRiskUterine Cervical NeoplasmsResearch Support as TopicProspective StudiesQuestionnairesGene Expression Regulation, NeoplasticDisease-Free SurvivalCombined Modality TherapyDatabases, FactualMice, NudeCarcinomaOdds RatioRepublic of KoreaDisease ProgressionCarcinoma, Non-Small-Cell LungTumor Markers, BiologicalDrug Resistance, NeoplasmNeoplasm ProteinsLogistic ModelsAmerican Cancer SocietySmokingSurvivorsNeoplasm Recurrence, LocalCancer VaccinesGenetic Predisposition to DiseaseUrinary Bladder NeoplasmsCanadaCarcinoma, Squamous CellCell Line, TumorBiomedical ResearchMultivariate AnalysisAcademies and InstitutesCohort StudiesEuropean Continental Ancestry GroupChemotherapy, AdjuvantTime FactorsRectal NeoplasmsCisplatinSex FactorsGreat BritainMammographyAdenocarcinomaPrevalenceFluorouracilProstate-Specific AntigenDrug Administration ScheduleReceptors, EstrogenKaplan-Meier EstimateGene Expression ProfilingResearch DesignReproducibility of ResultsNeoplasms, Second PrimaryQuality of LifeMutationHealth SurveysClinical Trials, Phase III as TopicRadiotherapyXenograft Model Antitumor AssaysPaclitaxelDose-Response Relationship, DrugSensitivity and SpecificityNational Library of Medicine (U.S.)Confidence IntervalsLiver NeoplasmsReceptor, erbB-2